These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34165557)

  • 1. Reliability of the AR-CALUX®In Vitro Method Used to Detect Chemicals with (Anti)Androgen Activity: Results of an International Ring Trial.
    Milcamps A; Liska R; Langezaal I; Casey W; Dent M; Odum J
    Toxicol Sci; 2021 Oct; 184(1):170-182. PubMed ID: 34165557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation and validation of an in vitro transactivation assay based on the 22Rv1/MMTV_GR-KO cell line to detect human androgen receptor agonists and antagonists.
    Park Y; Jung DW; Milcamps A; Takeyoshi M; Jacobs MN; Houck KA; Ono A; Bovee TFH; Browne P; Delrue N; Kang Y; Lee HS
    Food Chem Toxicol; 2021 Jun; 152():112206. PubMed ID: 33887398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and pre-validation of an in vitro transactivation assay for detection of (anti)androgenic potential compounds using 22Rv1/MMTV cells.
    Sun S; Park EJ; Choi YH; Lee HS; Ahn BY; Dong MS
    Reprod Toxicol; 2016 Apr; 60():156-66. PubMed ID: 26867867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interlaboratory prevalidation of a new in vitro transcriptional activation assay for the screening of (anti-)androgenic activity of chemicals using the UALH-hAR cell line.
    Garoche C; Grimaldi M; Michelin E; Boulahtouf A; Marconi A; Brion F; Balaguer P; Aït-Aïssa S
    Toxicol In Vitro; 2023 Apr; 88():105554. PubMed ID: 36641061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Computational Model for Androgen Receptor Activity.
    Kleinstreuer NC; Ceger P; Watt ED; Martin M; Houck K; Browne P; Thomas RS; Casey WM; Dix DJ; Allen D; Sakamuru S; Xia M; Huang R; Judson R
    Chem Res Toxicol; 2017 Apr; 30(4):946-964. PubMed ID: 27933809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of androgen receptor agonistic/antagonistic effects on 25 chemicals in household applicants by OECD in vitro stably transfected transcriptional activation assays.
    Lee HS; Park EJ; Han S; Oh GY; Kang HS; Suh JH; Shin MK; Oh HS; Hwang MS; Moon G; Koh YH; Park Y; Hong JH; Koo YE
    Chemosphere; 2018 Jan; 191():589-596. PubMed ID: 29073568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine disrupting potential of veterinary drugs by in vitro stably transfected human androgen receptor transcriptional activation assays.
    Park Y; Park J; Lee HS
    Environ Pollut; 2021 Oct; 286():117201. PubMed ID: 33965802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic depsipeptide mycotoxin exposure may cause human endocrine disruption: Evidence from OECD in vitro stably transfected transcriptional activation assays.
    Park Y; Lee HS
    Reprod Toxicol; 2021 Mar; 100():52-59. PubMed ID: 33346041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
    van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S
    Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a rapid in vitro androgen receptor transcriptional activation assay using AR-EcoScreen cells.
    Araki N; Ohno K; Takeyoshi M; Iida M
    Toxicol In Vitro; 2005 Apr; 19(3):335-52. PubMed ID: 15713541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of androgen transcriptional activation assay based on genome edited glucocorticoid knock out human prostate cancer cell line.
    Lee HS; Lee SH; Park Y
    Environ Res; 2019 Apr; 171():437-443. PubMed ID: 30735951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
    Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ
    Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The triazole fungicide metconazole inhibits the homodimerization of human androgen receptors to suppress androgen-induced transcriptional activation.
    Jung DW; Jeong DH; Kim UJ; Lee HS
    Chem Biol Interact; 2023 Jun; 378():110489. PubMed ID: 37059213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
    Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based discovery of the endocrine disrupting effects of hydraulic fracturing chemicals as novel androgen receptor antagonists.
    Tachachartvanich P; Azhagiya Singam ER; Durkin KA; Smith MT; La Merrill MA
    Chemosphere; 2020 Oct; 257():127178. PubMed ID: 32505947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
    Wilson VS; Bobseine K; Lambright CR; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
    Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
    Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating true androgen receptor inhibition from cytotoxicity-mediated reduction of reporter-gene transactivation in-vitro.
    Marin-Kuan M; Fussell KC; Riederer N; Latado H; Serrant P; Mollergues J; Coulet M; Schilter B
    Toxicol In Vitro; 2017 Dec; 45(Pt 3):359-365. PubMed ID: 28377212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupling the H295R with ERα and AR U2OS CALUX assays enables simultaneous testing for estrogenic, anti-androgenic and steroidogenic modalities.
    Nikopaschou MS; Félix A; Mollergues J; Scholz G; Schilter B; Marin-Kuan M; Fussell KC
    Toxicol Sci; 2023 Jul; 194(2):191-208. PubMed ID: 37261848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insight into human androgen receptor-mediated endocrine-disrupting potentials by a stable bioluminescence resonance energy transfer-based dimerization assay.
    Lee SH; Hong KY; Seo H; Lee HS; Park Y
    Chem Biol Interact; 2021 Nov; 349():109655. PubMed ID: 34520754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.